A Natural Choice
For Hemophilia A treatment.
Expressed in a human cell line.
No chemical modifications.
Previously Treated Patients (PTPs)
PTPs can benefit from the safety and bleed protection
Previously Untreated Patients (PUPs)
In the NuProtect study, PUPs experienced a low rate of inhibitor development with NUWIQ.
Experience the safety, effectiveness, and convenience of NUWIQ at no cost.
Octapharma can provide savings on some of the costs associated with your NUWIQ treatment.
Factor VIII is the Standard Of Care
FVIII replacement therapy is the standard of care for Hemophilia A.1 FVIII replacement is a trusted therapy that has been proven to be safe and effective over decades of use.
- Cafuir LA, Kempton CL. Ther Adv Hematol. 2017;8(10):303-313